Rybelsus 7 mg is a tablet that contains semaglutide, a drug that helps lower blood sugar levels in adults with type 2 diabetes. It is usually taken once daily along with diet and exercise.
Rybelsus 7 mg contains Semaglutide, a drug that belongs to the class of GLP-1 receptor agonists. It is designed to help control blood glucose levels and is typically prescribed when diet and exercise alone are not sufficient.
Unlike many other medications in its class, Rybelsus is taken by mouth (tablet form) rather than by injection.
Semaglutide works by mimicking a natural hormone (GLP-1), leading to:
Increased insulin secretion when blood sugar is high
Decreased glucagon release
Slower gastric emptying
Reduced appetite in some patients
Taken once daily, usually on an empty stomach
Swallowed with a small amount of water
Patients should wait at least 30 minutes before eating or drinking
Helps lower HbA1c (long-term blood sugar levels)
May support weight reduction in some individuals
Convenient oral alternative to injectable GLP-1 drugs
Nausea
Vomiting
Diarrhea
Abdominal discomfort
Not suitable for Type 1 Diabetes
Use cautiously in patients with a history of pancreatitis
Should only be used under medical supervision
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.